← Back to all trials
Completed
NCT04044534
Intranasal Insulin for Posttraumatic Stress Disorder
Conditions: PTSD
Sex: All
Ages: 21 Years – 65 Years
Healthy volunteers: No
Phase: PHASE2
Enrollment: 10
Sponsor: VA Connecticut Healthcare System
Location: VA Connecticut Healthcare System West Haven Connecticut
Summary
To evaluate if intranasal insulin is effective in reducing PTSD symptoms.
Eligibility Criteria
Inclusion Criteria:
* Male or female, 21-65 years old
* Current PTSD
* Able to provide written informed consent
Exclusion Criteria:
* Unstable medical condition, clinically determined by a physician
* Diabetes requiring insulin or oral hypoglycemic agents
* Moderate-severe traumatic brain injury
* Current psychotic disorder, bipolar disorder, cognitive disorder in the past 12 months
* Current substance use disorders (except alcohol, tobacco, or cannabis) in the past 3 months
* Changes in doses of psychotropic medications in the past 4 weeks
* Initiation of individual therapy or counseling in the past 4 weeks
* Imminent suicidal or homicidal risk
* Contraindication to Insulin
* History of claustrophobia
* Presence of cardiac pacemaker or other electronic device or ferromagnetic metal foreign bodies in vulnerable positions as assessed by a standard pre-MRI safety screening questionnaire
Source: ClinicalTrials.gov (NCT04044534). StuddyBuddy aggregates publicly available trial information.